STOCK TITAN

Director Dorothy Puhy granted 50,913 MDXG shares in annual stock award

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PUHY DOROTHY E reported acquisition or exercise transactions in this Form 4 filing.

MiMedx Group director Dorothy E. Puhy received a grant of 50,913 shares of common stock at $3.64 per share as an annual restricted stock award for non-employee directors. This compensation-related grant, exempt under Rule 16b-3, will vest upon the earlier of 12 months or the next shareholder meeting. Following the award, she directly holds 108,510 shares of MiMedx common stock.

Positive

  • None.

Negative

  • None.
Insider PUHY DOROTHY E
Role null
Type Security Shares Price Value
Grant/Award Common Stock 50,913 $3.64 $185K
Holdings After Transaction: Common Stock — 108,510 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Restricted stock grant 50,913 shares Annual stock award to non-employee director
Grant price $3.64 per share Value used for the 50,913-share award
Total holdings after grant 108,510 shares Director’s direct MiMedx common stock position post-award
Vesting period Earlier of 12 months or next shareholder meeting Restricted stock vesting condition
restricted stock financial
"Represents annual restricted stock grant to non-employee directors."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Rule 16b-3 regulatory
"Grant is exempt under Rule 16b-3."
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
non-employee directors financial
"Represents annual restricted stock grant to non-employee directors."
Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PUHY DOROTHY E

(Last)(First)(Middle)
1775 WEST OAK COMMONS CT NE

(Street)
MARIETTA GEORGIA 30062

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MIMEDX GROUP, INC. [ MDXG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/10/2026A50,913(1)A$3.64108,510D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next meeting of shareholders.
Remarks:
/s/ William F. Hulse as attorney-in-fact Dorothy Puhy06/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Dorothy E. Puhy report for MIMEDX (MDXG)?

Director Dorothy E. Puhy reported receiving a grant of 50,913 shares of MiMedx common stock as restricted stock. The award is part of annual compensation for non-employee directors and is classified as a grant or award acquisition rather than an open-market purchase.

How many MDXG shares did Dorothy Puhy receive and at what price?

Dorothy Puhy received 50,913 shares of MiMedx common stock, valued using a grant price of $3.64 per share. This was an equity compensation award, not a market trade, and increased her direct holdings to a larger overall share position in the company.

What are Dorothy Puhy’s total MDXG holdings after this Form 4 transaction?

After the restricted stock grant, Dorothy Puhy directly holds 108,510 shares of MiMedx common stock. This total reflects her position immediately following the award and helps show the scale of the grant relative to her overall ownership stake as a director.

Is Dorothy Puhy’s MDXG Form 4 transaction a stock purchase or compensation grant?

The Form 4 reports a compensation grant, not an open-market purchase. The 50,913 shares of MiMedx common stock were awarded as annual restricted stock to a non-employee director, categorized as a grant or award acquisition under SEC transaction code A.

When does Dorothy Puhy’s restricted MDXG stock award vest?

The restricted stock award will vest upon the earlier of 12 months or the next MiMedx shareholder meeting. This means vesting is tied to either the passage of time or the company’s upcoming shareholder meeting, providing a defined horizon for the restrictions to lapse.

What does Rule 16b-3 exemption mean for Dorothy Puhy’s MDXG stock grant?

The filing notes the grant is exempt under Rule 16b-3, which generally covers board-approved compensation for insiders. This exemption indicates the award follows specific SEC rules for director and officer equity compensation, reducing certain short-swing profit liability concerns.